Benchmark Lowers Harvard Bioscience (NASDAQ:HBIO) Price Target to $4.50

Harvard Bioscience (NASDAQ:HBIO) had its price objective reduced by Benchmark from $5.50 to $4.50 in a report issued on Monday morning,Benzinga reports. They currently have a speculative buy rating on the medical instruments supplier’s stock.

Harvard Bioscience Price Performance

Shares of NASDAQ:HBIO opened at $0.60 on Monday. Harvard Bioscience has a fifty-two week low of $0.59 and a fifty-two week high of $4.70. The company’s 50-day moving average is $1.25 and its 200 day moving average is $1.97. The company has a market capitalization of $26.40 million, a P/E ratio of -1.81 and a beta of 1.46. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.91 and a current ratio of 2.06.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. GSA Capital Partners LLP bought a new stake in Harvard Bioscience during the third quarter worth about $30,000. Focus Partners Wealth purchased a new position in Harvard Bioscience during the 4th quarter valued at $28,000. Avior Wealth Management LLC lifted its holdings in Harvard Bioscience by 1,118.1% in the third quarter. Avior Wealth Management LLC now owns 14,569 shares of the medical instruments supplier’s stock worth $39,000 after buying an additional 13,373 shares during the period. Intech Investment Management LLC purchased a new position in shares of Harvard Bioscience in the 4th quarter valued at approximately $35,000. Finally, Landscape Capital Management L.L.C. bought a new stake in shares of Harvard Bioscience during the 3rd quarter valued at $50,000. Institutional investors own 80.87% of the company’s stock.

About Harvard Bioscience

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.